U.S. Markets closed

Trevena, Inc. (TRVN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.22000.0000 (0.00%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.2200
Open1.2700
Bid1.2100 x 4000
Ask1.2400 x 800
Day's Range1.2200 - 1.2775
52 Week Range1.0910 - 3.4000
Volume756,503
Avg. Volume1,530,379
Market Cap199.583M
Beta (5Y Monthly)2.45
PE Ratio (TTM)N/A
EPS (TTM)-0.2330
Earnings DateNov 01, 2021 - Nov 05, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.33
  • GlobeNewswire

    Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences & MedTech Summit

    CHESTERBROOK, Pa., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Carrie Bourdow, President and Chief Executive Officer of Trevena, will present at the Oppenheimer 2021 Fall Healthcare Life Sciences & MedTech Summit being held virtually from September 20th – 23rd. Presentation Details Date: Tuesday, Septem

  • GlobeNewswire

    Trevena to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

    CHESTERBROOK, Pa., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Carrie Bourdow, President and Chief Executive Officer of Trevena, will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually from September 13th - 15th. Presentation Details Date: Monday, September 13th

  • GlobeNewswire

    Trevena Announces Two OLINVYK® Abstracts Highlighting Safety Data Accepted at ANESTHESIOLOGY® 2021

    CHESTERBROOK, Penn., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced the acceptance of two abstracts at ANESTHESIOLOGY® 2021. Both abstracts highlight safety data from the OLINVYK (oliceridine) injection program. The meeting is sponsored by the American Society of Anesthesiologists and will be held on October 8th